Loading
Latest filing published 05 Jan 2026 for Keenova Therapeutics plc. Read the official filing
No signal scores available.
All filings by Mark Anthony Tyndall on record concern Mallinckrodt plc. In total, 5 filings cover trades dated from 14 December 2022 to 1 January 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 5 January 2026 came the latest disclosure, an option exercise in Mallinckrodt plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations